- Home
- GNLX vs LENZ Comparison
GNLX vs LENZ Comparison
Compare GNLX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | LENZ |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 106.8M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GNLX | LENZ |
|---|---|---|
| Price | $1.99 | $3.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $18.83 | $15.00 |
| AVG Volume (30 Days) | 439.5K | ★ 1.2M |
| Earning Date | 11-17-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,000.00 | ★ $19,088,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $140.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $2.80 |
| 52 Week High | $6.26 | $32.13 |
Technical Indicators
Market Signals| Indicator | GNLX | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 44.70 |
| Support Level | $1.86 | N/A |
| Resistance Level | $2.82 | $6.11 |
| Average True Range (ATR) | 0.23 | 0.30 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 21.97 | 45.70 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.